The Brains Behind a Company Launch
BlackThorn is a clinical-stage biopharmaceutical company that uses a proprietary platform linking behavioral deficits with brain physiology to discover and develop targeted treatments for neurobehavioral disorders such as autism spectrum disorder, obsessive-compulsive disorder, depression and schizophrenia.
We worked with BlackThorn to build a narrative as the company prepared to announce their launch and Series A closing. Leading up to this milestone, we partnered to build their positioning platform and solidify their messaging.
We refreshed their logo with a focus on scalability and reproducibility and designed and developed an engaging yet streamlined website on a user-friendly back end. The website is inclusive of a responsive and interactive pipeline module that can be updated from the content management system and toggled to reveal information about BlackThorn’s programs in the clinic.
In addition to developing and executing on a launch communications media strategy, we supported BlackThorn on subsequent announcements, including an extension of their Series A and the hire of their CEO.